The Effect of Thiamine in Reducing the Symptoms of Bortezomib-Induced Peripheral Neuropathy in Patients with Multiple Myeloma

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MEHRZAD VALIOLLAH; Rafiaei Ghazal

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S) Year:2019 | Volume:37 | Issue:555 Page(s): 1347-1353

Download Full-Text

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

View:

466

Download:

Cites:

Information Journal Paper

Title

The Effect of Thiamine in Reducing the Symptoms of Bortezomib-Induced Peripheral Neuropathy in Patients with Multiple Myeloma

Author(s)

MEHRZAD VALIOLLAH | Rafiaei Ghazal | Issue Writer Certificate

Keywords

BortezomibQ1

Vitamin B1Q2

NeuropathyQ3

Multiple myelomaQ1

Abstract

Background: Peripheral Neuropathy is one of the most frequent side effects of Bortezomib-based chemotherapy, which has the most important role in treatment of Multiple myeloma. Various supplements including vitamin B group complex have been examined to prevent and treat Bortezomib-induced peripheral Neuropathy (BIPN), but there is no definite recommendation yet. We aimed to evaluate the role of Vitamin B1 (thiamine) in prevention of BIPN in patients with Multiple myeloma. Methods: This was a randomized controlled clinical trial study. Patients with Multiple myeloma who were supposed to receive 4 months of Bortezomib-based chemotherapy were enrolled the study and divided into two groups. The intervention group received thiamine at a dose of 300 mg per day from the beginning of treatment schedules, and the control group were observed during treatment. For assessment, we used symptoms experience questionnaire that was completed after 4 months. Findings: 29 patients were enrolled in Vitamin B1 group and 29 others in control group. Peripheral Neuropathy score significantly decreased after intervention with Vitamin B1 in comparison with control group (P < 0. 0001). Conclusion: The findings demonstrate that Vitamin B1 has a significant effect on preventing and reducing the severity of peripheral Neuropathy in BIPN.

Cites

No record.

References

No record.

Cite

APA: Copy

MEHRZAD, VALIOLLAH, & Rafiaei, Ghazal. (2019). The Effect of Thiamine in Reducing the Symptoms of Bortezomib-Induced Peripheral Neuropathy in Patients with Multiple Myeloma. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), 37(555 ), 1347-1353. SID. https://sid.ir/paper/395986/en

Vancouver: Copy

MEHRZAD VALIOLLAH, Rafiaei Ghazal. The Effect of Thiamine in Reducing the Symptoms of Bortezomib-Induced Peripheral Neuropathy in Patients with Multiple Myeloma. JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S)[Internet]. 2019;37(555 ):1347-1353. Available from: https://sid.ir/paper/395986/en

IEEE: Copy

VALIOLLAH MEHRZAD, and Ghazal Rafiaei, “The Effect of Thiamine in Reducing the Symptoms of Bortezomib-Induced Peripheral Neuropathy in Patients with Multiple Myeloma,” JOURNAL OF ISFAHAN MEDICAL SCHOOL (I.U.M.S), vol. 37, no. 555 , pp. 1347–1353, 2019, [Online]. Available: https://sid.ir/paper/395986/en

Related Journal Papers